Tiếng Việt
General description
LiChrosorb® RP-8 HPLC column is used for the separation of neutral, acidic and weakly basic compounds.
Application
Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography.: Utilizing the LiChrospher® RP-8 HPLC Column, this study develops a method for analyzing various formulations of amphotericin B in plasma, crucial for monitoring therapeutic levels and preventing toxicity in patients undergoing antifungal treatment (Egger et al., 2001).
Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatography.: This research demonstrates the application of the LiChrospher® RP-8 HPLC Column in the quantification of doxorubicin and its metabolites, enhancing the understanding of its pharmacokinetics and aiding in the optimization of cancer treatment regimens (van Asperen et al., 1998).
Determination of glibenclamide in human plasma by solid-phase extraction and high-performance liquid chromatography.: Employing the LiChrospher® RP-8 HPLC Column, this method provides accurate and reliable quantification of glibenclamide, a critical component in managing diabetes mellitus (Valdes Santurio and Gonzalez Porto, 1996).
Simultaneous determination of ampicillin and metampicillin in biological fluids using high-performance liquid chromatography with column switching.: Highlighting the versatility of the LiChrospher® RP-8 HPLC Column, this study develops a technique for the simultaneous determination of ampicillin and its prodrug, metampicillin, crucial for effective antibiotic therapy monitoring (Lee et al., 1995).
Other Notes
Discover LiChropur reagents ideal for HPLC or LC-MS analysis
Legal Information
LiChrosorb is a registered trademark of Merck KGaA, Darmstadt, Germany
LiChrospher is a registered trademark of Merck KGaA, Darmstadt, Germany
